Navigation Links
Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
Date:5/2/2008

-Memory Receives $6 Million Milestone Payment-

-Memory to Host Conference Call at 9:00 a.m. EDT Today-

MONTVALE, N.J. and BASEL, Switzerland, May 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) and Roche (SWX: ROG) today announced that Roche has exercised its option to further develop and commercialize Memory Pharmaceuticals' lead nicotinic alpha-7 agonist drug candidate, MEM 3454, for neurological and psychiatric disorders. Roche's exercise of its option for MEM 3454 triggers a $6 million milestone payment and entitles Memory Pharmaceuticals to future payments upon the achievement of additional milestones and royalties on product sales, including a $17 million milestone payment upon the completion of the ongoing Phase 2a study in cognitive impairment associated with schizophrenia (CIAS). In addition, Memory Pharmaceuticals retains an option to co-promote MEM 3454 in the United States.

"We are excited that Roche shares our enthusiasm for MEM 3454 and its potential to address the cognitive deficits associated with debilitating CNS disorders," stated Vaughn M. Kailian, President and Chief Executive Officer of Memory Pharmaceuticals. "We have aggressively advanced MEM 3454 through early-stage clinical trials, including a positive Phase 2a trial in Alzheimer's disease. We believe that Roche's continued commitment to the program, together with its expertise in later-stage clinical development and commercialization, will provide the support and capabilities to realize the full potential of this compound."

In a recently completed Phase 2a study in Alzheimer's disease patients, MEM 3454 demonstrated a statistically significant effect on multiple measures of cognition. The compoun
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
2. MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
3. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
4. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
5. Roche responds to announcement of IDEAL hepatitis C trial results
6. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
7. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
8. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
9. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
10. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
11. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...v.24/PRNewswire-Asia/--HuifengBio-Pharmaceutical,T...loperandproducer,ofplantextractsandpharmaceuticalr...dfoodproductioninXi,an,China,todayreportedthatinit...enues. , RevenuesforthequarterendedSept.30,20...3,534,623forthesamequarterin2008.Netincome,amounte...
(Date:11/24/2009).../PRNewswire-Asia-FirstCall/--LotusPharmaceuticals,...)agrowingdeveloperand,producerofprescriptionsdrugs...inthePeople,sRepublicChina,todayreporteditwillexhi...ceuticaldelegation. ,, Time:November26-28,200...du ,, TheBeijingdelegationfeaturesmorethantwe...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--NeurocrineBiosciences,Inc...identandChiefExecutiveOfficerofNeurocrineBioscienc...thCareConferenceinNewYork. ,, Thelivepresentati...nTime(ET)/1:30p.m.PacificTime(PT).Thepresentationw...pany,swebsiteat http://www.neurocrine.com . ,, ...
Breaking Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2DEET in Bug Spray Tied to Neural Damage in Mice 53713 1DEET in Bug Spray Tied to Neural Damage in Mice 53713 2DEET in Bug Spray Tied to Neural Damage in Mice 53713 3SimplyAgeless Believes Michael Jackson Could Have Been Going Through Male Menopause 53710 1SimplyAgeless Believes Michael Jackson Could Have Been Going Through Male Menopause 53710 2Sanofi Aventis Recognized for Workplace Efforts to Prevent Cancer 53707 1Sanofi Aventis Recognized for Workplace Efforts to Prevent Cancer 53707 2Sanofi Aventis Recognized for Workplace Efforts to Prevent Cancer 53707 3
...A. Rumberger and KGK Synergize Will Study Ingredie... 25 Daiichi Fine Chemical Co., Ltd. of,Japan toda...rdiologist Dr.,John A. Rumberger and the Contract ...a new clinical trial to investigate the effect of ...ement and the reduction of cardiovascular,risk fac...
...e Biosciences Demonstrates Rapid and Significant P... invivodata inc., the industry,leader in electron...services for global clinical research, today annou...was used to capture important secondary efficacy,e...NBIX ) PETAL study, a,Phase II clinical trial of i...
Other Medicine Technology:Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels 2Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels 3invivodata Captures Symptom Relief Data in Endometriosis Trial 2
(Date:11/24/2009)...BuyTargetingAK,AR,FL,IN,LA,ME,NE,NDandSD ,, AL...ewakeoftheSenate,svoteonSaturdaytotakeupthehealthc...uncedanewadvertisingcampaigntargetingSenatorsinnin...Maine,Nebraska,NorthDakota,andSouthDakota. ,, T...dMedicaidServices(CMS)reportwhichconfirmscutstoMed...
(Date:11/24/2009)...PRNewswire/--Metastorm,aleadingproviderofBusinessP...,andEnterpriseArchitecture(EA)softwareforalignings...isourceBergenCorporation,oneoftheworld,slargestpha...orNorthAmericainthe2009GlobalAwardsforExcellencein...lementationofMetastorm,sBPMsoftware.Theawardrecogn...
(Date:11/24/2009)...24/PRNewswire/--Thankstoaninnovativeprogramrecentl...S)andAnthemBlueCrossandBlueShieldinMaine,someAnthe...ysicianwithoutleavinghome. ,, Aspartofthepilot,...questionsandcommunicateviaemailwiththeirproviderab...tments,checkingontestresults,orrequestingprescript...
(Date:11/24/2009)...ble in French and Spanish . , Researchers...de gene, called ,gene E, which leads to the death...on cancer, and prevents their growth. The importan...r can reduce the potent drugs that are currently u...or cancer. , This research was conducted by Ana...
(Date:11/24/2009)...ble in German . , Internationally viewed, m... very good as far as survival is concerned. Howeve...nd long-term consequences of the disease are still...he conclusion of the Institute for Quality and Eff... published on 16 October 2009. , Establish mand...
Breaking Medicine News(10 mins):Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2Health News:The Doctor Will See You Now. . .Online 2Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3
...rch has revealed that anti-retrovirals (ARVs) in H...-infection has been known to cause mental illness/...0% of Aids sufferers having major depression in So...credible response that patients have to ARVs in th...
...biological irony, the same white blood cell chemis...ay also help prevent such damage, according to a f...mice at Johns Hopkins. Researchers have long...ic natural chemicals that contribute to ischemic r...
...rsity School of Medicine researchers have found hi...families in eastern and western North Carolina,// ...lthough the United States enjoys a relative lack o...aid Sara A. Quandt, Ph.D. The overall hunger...
...oposes to revive the thorny issue of making a one-... said Health Minister Anbumani Ramadoss Friday.// ...December and placed before the cabinet, the minist...o the cabinet for clearance of the proposal," he s...
...ing her first ever public appearance, since her ar...angerous injections, confirmed that neither she no...r charge. The charge labeled against them b...idavit of the case, confirms that Dr.Pou along wit...
...study has revealed that throwing raw eggs at peopl...y result in serious eye injury.// The study h...l which revealed that grave eye injuries could res...from November 2004 to December 2005. Among th...
Other Medicine News:Health News:White Blood Cells Can Both Hurt and Help Transplanted Kidneys 2Health News:White Blood Cells Can Both Hurt and Help Transplanted Kidneys 3Health News:Surveys Find Outright Hunger among Latino Immigrants in North Carolina 2Health News:Surveys Find Outright Hunger among Latino Immigrants in North Carolina 3Health News:Compulsory Rural Stint for Doctors: Ramadoss 2
Sugita Aneurysm Clip Angled (S)
Sugita Aneurysm Clip L-Shaped Cvd. To R(L)
Sugita Aneurysm Clip L-Shaped Cvd. To L(M)
Sugita Aneurysm Clip Bent (L)
Medicine Products: